BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16720930)

  • 1. Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma.
    Avilés A; Neri N; Nambo MJ; Huerta-Guzman J; Cleto S
    Med Oncol; 2006; 23(2):295-300. PubMed ID: 16720930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
    Avilés A; García EL; Fernández R; Gonzalez JL; Neri N; Díaz-Maqueo JC
    Ann Hematol; 2002 Jul; 81(7):368-73. PubMed ID: 12185505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and therapeutic management of gastric lymphomas].
    Grau E; Perella M; Gómez A; Pastor E; Mirabet MD; García F; Ibáñez JL; Aguiló J
    Sangre (Barc); 1996 Apr; 41(2):109-14. PubMed ID: 9045350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study.
    De Lena M; Ditonno P; Lorusso V; Brandi M; Timurian A; Marzullo F; Ventrella V; Pellecchia A
    J Clin Oncol; 1995 Apr; 13(4):953-60. PubMed ID: 7535844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha 2b as maintenance therapy improves outcome in follicular lymphoma.
    Avilés A; Neri N; Huerta-Guzmán J; Pérez F; Sotelo L
    Leuk Lymphoma; 2004 Nov; 45(11):2247-51. PubMed ID: 15512813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.
    Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U
    Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
    Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies.
    Avilés A; Nambo MJ; Talavera A; Garcia EL; Huerta-Guzman J; Díaz Maqueo JC
    Anticancer Drugs; 1997 Nov; 8(10):937-42. PubMed ID: 9436636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial.
    Avilés A; Nambo MJ; Neri N; Talavera A; Cleto S
    Med Oncol; 2005; 22(1):57-62. PubMed ID: 15750197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary?
    Raderer M; Chott A; Drach J; Montalban C; Dragosics B; Jäger U; Püspök A; Osterreicher C; Zielinski CC
    Ann Oncol; 2002 Jul; 13(7):1094-8. PubMed ID: 12176789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma.
    Lambertenghi Deliliers G; Butti C; Baldini L; Ceriani A; Lombardi F; Luoni M; Montalbetti L; Pavia G; Pinotti G; Pogliani E
    Haematologica; 1995; 80(4):318-24. PubMed ID: 7590500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of cyclophosphamide,epirubicin, vincristine, prednisone, and etoposide (CEOP-E) for aggressive non-Hodgkin 's lymphoma.
    Kim JG; Sohn SK; Kim DH; Baek JH; Park TI; Lee KB
    J Korean Med Sci; 2004 Dec; 19(6):820-5. PubMed ID: 15608392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma.
    Pinotti G; Zucca E; Roggero E; Pascarella A; Bertoni F; Savio A; Savio E; Capella C; Pedrinis E; Saletti P; Morandi E; Santandrea G; Cavalli F
    Leuk Lymphoma; 1997 Aug; 26(5-6):527-37. PubMed ID: 9389360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and prognostic factors of primary gastric lymphoma: A retrospective study with 165 cases.
    Wang YG; Zhao LY; Liu CQ; Pan SC; Chen XL; Liu K; Zhang WH; Yang K; Chen XZ; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
    Medicine (Baltimore); 2016 Aug; 95(31):e4250. PubMed ID: 27495029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide, epirubicin, vincristine, prednisone, bleomycin, etoposide (CEOP-BE) therapy for intermediate- and high-grade non-Hodgkin's lymphomas.
    Mugitani A; Tatsumi Y; Tanaka K; Yasui Y; Inoue T
    Anticancer Res; 1999; 19(4C):3393-7. PubMed ID: 10629625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
    Martelli M; Gherlinzoni F; De Renzo A; Zinzani PL; De Vivo A; Cantonetti M; Falini B; Storti S; Meloni G; Rizzo M; Molinari AL; Lauria F; Moretti L; Lauta VM; Mazza P; Guardigni L; Pescarmona E; Pileri SA; Mandelli F; Tura S
    J Clin Oncol; 2003 Apr; 21(7):1255-62. PubMed ID: 12663712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial.
    Hertzberg M; Matthews JP; Stone JM; Dubosq MC; Grigg A; Ellis D; Benson W; Browett P; Horvath N; Januszewicz H; Abdi E; Green M; Bonaventura A; Marlton P; Cannell P; Wolf M;
    Am J Hematol; 2014 May; 89(5):536-41. PubMed ID: 24481640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphoma.
    Avilés A; Nambo MJ; Neri N; Talavera A; Castañeda C; Murillo E; Cleto S; Huerta-Guzmán J
    Med Oncol; 2004; 21(3):269-72. PubMed ID: 15456955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
    Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations of primary pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in Japanese population.
    Ogusa E; Tomita N; Ishii Y; Takasaki H; Hattori Y; Matsumoto C; Ishigatsubo Y
    Hematol Oncol; 2013 Mar; 31(1):18-21. PubMed ID: 22278757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.